Blood product use in cardiac revascularization: Comparison of on- and off-pump techniques

被引:91
作者
Nader, ND
Khadra, WZ
Reich, NT
Bacon, DR
Salerno, TA
Panos, AL
机构
[1] Vet Adm Western New York Healthcare Syst, Buffalo, NY USA
[2] SUNY Buffalo, Div Cardiothorac Surg, Buffalo, NY 14260 USA
[3] SUNY Buffalo, Dept Anesthesia, Buffalo, NY 14260 USA
关键词
D O I
10.1016/S0003-4975(99)00827-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Cardiac revascularization on a beating heart avoids the side effects of cardiopulmonary bypass leg, neurologic injury, hemodilution, and coagulopathy). We examined perioperative bleeding and use of blood products during coronary artery bypass grafting using either on-pump or off-pump techniques. Method. The charts of 126 patients who had coronary artery bypass grafting were reviewed. Data from 66 patients revascularized off pump and 60 patients with cardiopulmonary bypass ton pump) were analyzed using unpaired Student's t test. Results. Average age was 62.5 years in either group. More patients received heparin preoperatively in the off-pump group that resulted in mild elevation of preoperative partial thromboplastin time and activated clotting time (40.4 +/- 2.9 seconds and 150.1 +/- 5.3 seconds, respectively). However, the off-pump group had less perioperative (intraoperative or postoperative) bleeding (2312 +/- 212 mt versus 3251 +/- 155 mt, p < 0.05) and required fewer blood products compared with the on-pump group. Hemoglobin and platelets decreased more in the conventional on-pump group. Conclusions. Avoiding cardiopulmonary bypass decreases perioperative bleeding and, consequently, reduces the use of blood products after coronary artery bypass grafting, which might result in fewer transfusion-related complications. (C) 1999 by The Society of Thoracic Surgeons.
引用
收藏
页码:1640 / 1643
页数:4
相关论文
共 15 条
[1]   TO USE OR NOT TO USE PUMP OXYGENATOR IN CORONARY-BYPASS OPERATIONS [J].
ANKENEY, JL .
ANNALS OF THORACIC SURGERY, 1975, 19 (01) :108-109
[2]   RESIDUAL COGNITIVE DYSFUNCTIONING AT 6 MONTHS FOLLOWING CORONARY-ARTERY BYPASS GRAFT-SURGERY [J].
BRUGGEMANS, EF ;
VANDIJK, JG ;
HUYSMANS, HA .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1995, 9 (11) :636-643
[3]  
BUFFOLO E, 1985, THORAC CARDIOV SURG, V33, P26
[4]   Coronary artery bypass grafting without cardiopulmonary bypass [J].
Buffolo, E ;
deAndrade, JCS ;
Branco, JNR ;
Teles, CA ;
Aguiar, LF ;
Gomes, WJ .
ANNALS OF THORACIC SURGERY, 1996, 61 (01) :63-66
[5]   Effects of tumour necrosis factor-α on the coronary circulation of the rat isolated perfused heart:: a potential role for thromboxane A2 and sphingosine [J].
Edmunds, NJ ;
Woodward, B .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (03) :493-498
[6]  
Favaloro R G, 1968, Ann Thorac Surg, V5, P334
[7]   AORTOCORONARY BYPASS WITH SAPHENOUS VEIN GRAFT - 7-YEAR FOLLOW-UP [J].
GARRETT, HE ;
DENNIS, EW ;
DEBAKEY, ME .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 223 (07) :792-794
[8]  
HARMON DE, 1996, ANN THORAC SURG S, V61, pS33
[9]   Comprehensive multimodality blood conservation: 100 consecutive CABG operations without transfusion [J].
Helm, RE ;
Rosengart, TK ;
Gomez, M ;
Klemperer, JD ;
DeBois, WJ ;
Velasco, F ;
Gold, JP ;
Altorki, NK ;
Lang, S ;
Thomas, S ;
Isom, OW ;
Krieger, KH .
ANNALS OF THORACIC SURGERY, 1998, 65 (01) :125-136